FEB 12, 2016 2:58 PM PST

Reprogramming Naive T Cells to Attack Cancerous B Cells

WRITTEN BY: Kara Marker
Acute lymphoblastic leukemia (ALL) and non-Hodgkin’s Lymphoma (NHL) affect 75,000 and 72,000 people each year in the United States, respectively. In addition to immunotherapy, chemotherapy, radiation, and stem cell transplants are a few treatments used to fight these cancers, but thousands of Americans still die every year.
 
A new study from the Children’s Hospital of Philadelphia (CHOP) provides promising new findings to improve current chemotherapies for pediatric cancer. Together with the Perelman School of Medicine at the University of Pennsylvania, CHOP researchers identified a specific sub-type of T lymphocytes to use for immunotherapy: the youngest cells.
 

 
Young T lymphocytes, characterized either as naïve cells or stem central memory cells, both expanded successfully in the lab and proved to be most efficient in attacking cancerous cells. The study was published last month in Science Translational Medicine.
 
The team of researchers observed 50 patients; all were either children or teenagers with B cell cancers. 38 of the 50 had ALL and 12 had NHL. By monitoring their T lymphocyte count every month for six months, the researchers were able to see positive change in the new immunotherapy using young T lymphocytes.
 
The therapy works by first taking out the patient’s T lymphocytes, tuning them to specifically find and kill cancerous B cells, and then returning them to the patient so they can work.
 
In the words of one of the study leaders, David M. Barrett, MD, PhD, "Collecting and expanding these cells could increase the number of children with cancer who could benefit from this innovative treatment."
 
Despite the clear success in the younger cells’ ability to kill cancer cells, they were also uniquely susceptible to chemotherapy, much more so than older T lymphocytes. In order to avoid elimination by chemicals from chemotherapy, which is almost always used in conjunction with immunotherapy at some point during cancer treatment, the researchers agreed that the young T lymphocytes would have to be extracted before any chemotherapy is administered.
 
"We could keep the patient's early-lineage T cells in reserve, in case the patient needs them later,” Barrett said.
 
Although the immunotherapy with young T lymphocytes showed increased success in treating both ALL and NHL patients, ALL patients saw greater success because they had more young T lymphocytes to collect from than NHL patients. Thus, the fight against B cell cancers is far from over.
 
 
Source: Children’s Hospital of Philadelphia
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 06, 2020
Immunology
Resetting the Body's Danger Sensor
AUG 06, 2020
Resetting the Body's Danger Sensor
The human body has a sophisticated danger-sensing mechanism that alerts the immune system when something is not right. T ...
SEP 07, 2020
Immunology
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
SEP 07, 2020
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
The ability to edit the human genome using CRISPR has been heralded as a revolution in medicine. However, one of the big ...
SEP 15, 2020
Immunology
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
SEP 15, 2020
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
A therapeutic made from turmeric has been shown to help reduce the effects of a painful inflammatory eye condition in do ...
SEP 23, 2020
Immunology
Gene That Fuels Antibody Factories Discovered
SEP 23, 2020
Gene That Fuels Antibody Factories Discovered
Antibodies are Y-shaped proteins that play a central role in the immune system’s arsenal of germ-busting weapons. ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...